Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques

In the last few decades, Ebola virus (EBOV) has emerged periodically and infected people in Africa, resulting in an extremely high mortality rate. With no available prophylaxis or cure so far, a highly effective Ebola vaccine is urgently needed. In this study, we developed a novel chimpanzee adenovi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xi, Wang, Xiang, Song, Yufeng, Zhou, Ping, Li, Dapeng, Zhang, Chao, Jin, Xia, Huang, Zhong, Zhou, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711196/
https://www.ncbi.nlm.nih.gov/pubmed/31339465
http://dx.doi.org/10.1080/22221751.2019.1644968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711196/
https://www.ncbi.nlm.nih.gov/pubmed/31339465
http://dx.doi.org/10.1080/22221751.2019.1644968

Ejemplares similares